Extrahepatische Anwendung von Ultraschallkontrastmittel: Kommentar zu den EFSUMB-Leitlinien 2011

Dietrich,; Schreiber-Dietrich,; Hocke,

doi:10.1024/1661-8157/a001061

Cited by 4 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…DCE-US is a relatively novel method for the noninvasive quantification of the systemic circulation of different sonographically accessible parenchymatous organs and the gastrointestinal wall. [ 4 27 28 ] Reduction in metastatic gastrointestinal stromal tumor (GIST) vascularization after treatment with imatinib was evaluated using DCE-US and computed tomography (CT) scanning with the result of significant advantages for DCE-US due to earlier tumor response evaluation. [ 29 ] The CT technique is a volumetric or linear measurement method that does not assess the antivascular effects of the kinase inhibitors, so it is expected to reveal a response later than any DCE technique.…”

Section: Dynamic Contrast-enhanced Ultrasoundmentioning

confidence: 99%

Dynamic contrast-enhanced endoscopic ultrasound: A quantification method

Dietrich

Froehlich

et al. 2017

Endosc Ultrasound

View full text Add to dashboard Cite

Dynamic contrast-enhanced ultrasound (DCE-US) has been recently standardized by guidelines and recommendations. The European Federation of Societies for US in Medicine and Biology position paper describes the use for DCE-US. Comparatively, little is known about the use of contrast-enhanced endoscopic US (CE-EUS). This current paper reviews and discusses the clinical use of CE-EUS and DCE-US. The most important clinical use of DCE-US is the prediction of tumor response to new drugs against vascular angioneogenesis.

show abstract